Myocardial infarction without coronary artery atherosclerosis (MINOCA) — scientific interest or practical need?

Journal Title: Серце і судини - Year 2019, Vol 0, Issue 3

Abstract

In recent years, much attention has been paid to the diagnosis and treatment of myocardial infarction (MI) without obstructive coronary artery atherosclerosis (MINOCA). According to statistics, the average prevalence of MINOCA is 6 — 8 % of all cases of MI. The diagnostic criteria for MINOCA are: presence of criteria for MI, absence of obstructive coronary artery disease according to data of coronary angiography (including angiographic stenosis < 50 %); no other cause of myocardial damage. According to the consensus of the American Heart Association (AHA) (2019), the diagnosis of MINOCA includes 3 stages. In the first stage, reanalysis of the clinical situation should be performed to rule out alternative diagnoses. In the second stage, it is necessary to evaluate the functional reserve of blood flow, to exclude non‑ischemic mechanisms of damage with the help of instrumental methods of research. The third stage is carried out in a specialized clinic, where the etiological factors of MI are verified. The article presents a clinical case of MI in a patient of 26 years of age. The diagnosis was confirmed by an increased level of troponin, changes in the electrocardiogram, echocardiographic examination and magnetic resonance imaging. With CA performed within 12 hours from the onset of the disease, hemodynamically significant coronary artery constrictions were not detected. During the laboratory examination, a significant increase in the level of homocysteine was found — 69 μmol/l (norm < 12.0 μmol/l). Given the weighted heredity, the emergence of MI at a young age, the absence of triggering factors (medications, stress, excessive physical activity, trauma, etc.) and diseases (diabetes, systemic connective tissue disease), an increased level of homocysteine, the role of thrombosis is highly probable. The patient is advised to consult a hematologist to identify hereditary thrombophilia as the cause of thrombosis (while taking antiplatelet/anticoagulant therapy performance of the tests and their interpretation are incorrect). It is recommended to take an angiotensin‑converting enzyme inhibitor, clopidogrel 75 mg/day, rivaroxaban 2.5 mg 2 times a day; β‑blocker, statins. Given the high level of homocysteine, the patient should follow a diet rich in folic acid‑rich foods.

Authors and Affiliations

L.  O. Tkachenko, O.  A. Epantschintsevа, M.  V. Stan, S.  M. Sagura

Keywords

Related Articles

Experience of use of 2-ethyl-6-methyl-3-hydroxypyridine succinate in complex therapy of stable angina

The aim — to evaluate the efficacy and tolerability of the use of different doses (200 and 500 mg/day) of 2‑ethyl‑6‑methyl‑3‑hydroxypyridine succinate (Venokor, Lekhim, Ukraine) in the complex therapy of patients with co...

Register of percutaneous coronary interventions: expanded comparative analysis of results of 2016  and 20 17. From reperfusion paradox to decrease of mortality

Ukrainian Association of Interventional Cardiology established Percutaneous Coronary Interventions Registry (PCI Registry) in 2010. The first protocol was filled on 12.04.2010. By now (23.07.2018, 17 h 58 min) the Regist...

Experience in treatment of post-traumatic arteriovenous discharges syndrome resulting from gunshot wounds of the main vessels

The aim — to analyze the experience of surgical treatment of patients with posttraumatic arteriovenous discharges in the lower limbs. During the period of the Anti-Terrorist Operation in the east of Ukraine, 8 patients w...

The protective effect of alpha-lipoic acid on cardiovascular diseases caused by oxidative stress

The article is devoted to the consideration of protective properties of alpha-lipoic acid using in cardiac patients, including those with concomitant type 2 diabetes mellitus, which constitute a group of high and very hi...

Age and gender differences in phenotype of heart failure with preserved left ventricular ejection fraction in patients with arterial hypertension

The aim — to determine differences in the structure and function of the heart, arterial stiffness, resistive and pulsative loads and ventricular‑arterial connection in patients with arterial hypertension, confirmed heart...

Download PDF file
  • EP ID EP673890
  • DOI 10.30978/HV2019-3-60
  • Views 157
  • Downloads 0

How To Cite

L.  O. Tkachenko, O.  A. Epantschintsevа, M.  V. Stan, S.  M. Sagura (2019). Myocardial infarction without coronary artery atherosclerosis (MINOCA) — scientific interest or practical need?. Серце і судини, 0(3), 60-66. https://europub.co.uk./articles/-A-673890